Aytu BioScience Announces ZolpiMist Global Distribution Agreement with SUDA Pharmaceuticals, page-88

It’s obvious that Aytu know how to manage holder perceptions.
Even if it is simply a name change on the cheque, I can’t understand why we did not try and leverage off the fact that we are now working alongside a company that seems to not only be progressive, but also has the drive, resources and management to get Zolpimist pumping in the worlds largest market.. as far as our comms go, we seem to continually let the gold wash into the tailings...